Drs. Konsta and van der Horst-Bruinsma reply.

We thank Dr. Slouma et al 1 for their earnest interest in our recent article, which examined the prevalence and radiographic progression of hip involvement in patients with ankylosing spondylitis (AS) treated with tumor necrosis factor inhibitors (TNFi). 2 .